Literature DB >> 27689780

A policy of routine umbilical cord blood gas analysis decreased missing samples from high-risk births.

M Ahlberg1,2, C Elvander1, S Johansson1, S Cnattingius1, O Stephansson1,3.   

Abstract

AIM: This study compared obstetric units practicing routine or selective umbilical cord blood gas analysis, with respect to the risk of missing samples in high-risk deliveries and in infants with birth asphyxia.
METHODS: This was a Swedish population-based cohort study that used register data for 155 235 deliveries of live singleton infants between 2008 and 2014. Risk ratios and 95% confidence intervals were calculated to estimate the association between routine and selective umbilical cord blood gas sampling strategies and the risk of missing samples.
RESULTS: Selective sampling increased the risk ratios when routine sampling was used as the reference, with a value of 1.0, and these were significant in high-risk deliveries and birth asphyxia. The risk ratios for selective sampling were large-for-gestational age (9.07), preterm delivery at up to 36 weeks of gestation (8.24), small-for-gestational age (7.94), two or more foetal scalp blood samples (5.96), an Apgar score of less than seven at one minute (2.36), emergency Caesarean section (1.67) and instrumental vaginal delivery (1.24).
CONCLUSION: Compared with routine sampling, selective umbilical cord blood gas sampling significantly increased the risks of missing samples in high-risk deliveries and in infants with birth asphyxia. ©2016 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Birth asphyxia; Cord blood gas analysis; High-risk deliveries; Population-based cohort

Mesh:

Substances:

Year:  2016        PMID: 27689780     DOI: 10.1111/apa.13610

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  1 in total

1.  Opioid-Free Labor Analgesia: Dexmedetomidine as an Adjuvant Combined with Ropivacaine.

Authors:  Wei Gao; Jie Wang; Zhiguo Zhang; Haiying He; Huiwen Li; Ruili Hou; Liping Zhao; Daniel Muthee Gaichu
Journal:  J Healthc Eng       Date:  2022-03-29       Impact factor: 2.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.